OMER, ISRAEL--(Marketwired - May 9, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization ...
-MUSE™ offers millions of patients with reflux durable relief and the potential to eliminate the use of lifelong medication helping reduce healthcare costs- "Our main objective continues to be the ...
A study presented at Digestive Disease Week 2016 found Medigus’ MUSE system is a safe minimally-invasive alternative for the long-term treatment of gastroesophageal reflux disease. 1. Ali Lankarani, ...
OMER, ISRAEL--(Marketwired - May 9, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results